文献速递结核与非结核分枝杆菌

冈比亚研究:BCG疫苗对结核感染的保护随暴露水平变化

BCG Vaccine Protection Against Mycobacterium tuberculosis Infection by Level of Exposure in The Gambia.
PubMed 文献 · J Infect Dis · 2021-01-01

在冈比亚220名病例接触者中,采用暴露评分分层,评估BCG疫苗对3个月酶联免疫斑点试验阳转的保护效果。

要点

  • BCG对结核感染的保护在低暴露人群中更强。

核心结论

  • 冈比亚数据与印度尼西亚研究一致,BCG疫苗对结核感染的保护随暴露水平升高而减弱。

研究设计与样本

  • 泊松回归分析220名冈比亚病例接触者,按暴露评分分层,评估BCG对3个月酶联免疫斑点试验阳转的保护。

临床怎么用

  • 解读BCG保护效果时需考虑暴露水平,低暴露人群可能获益更明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Indonesia, BCG vaccine protection against Mycobacterium tuberculosis infection decreased with increasing exposure to the pathogen. We aimed to validate these findings in Africa. Poisson regression was used to estimate BCG protection, stratified by pathogen exposure using an exposure score, against enzyme-linked immunospot assay conversion at 3 months in 220 Gambian case contacts. Although the interaction between BCG and exposure was not significant (P = .13), BCG protection was strongest in the lowest-exposure tertile (relative risk, 0.35 [95% confidence interval, .15-.82; P = .02] vs 0.50 [.30-.83; P = .008] and 0.71 (.45-1.13; P = .1] for the middle and highest-exposure tertiles, respectively. These results are consistent with those from Indonesia.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Campbell N, Verrall AJ, Donkor S, et al. BCG Vaccine Protection Against Mycobacterium tuberculosis Infection by Level of Exposure in The Gambia. J Infect Dis. 2021. PMID: 32638004. doi:10.1093/infdis/jiaa411

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。